8.13
price up icon0.12%   0.07
 
loading
Novavax Inc stock is traded at $8.13, with a volume of 629.04K. It is up +0.12% in the last 24 hours and down -20.41% over the past month. Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
See More
Previous Close:
$8.06
Open:
$8
24h Volume:
629.04K
Relative Volume:
0.10
Market Cap:
$1.28B
Revenue:
$793.74M
Net Income/Loss:
$-398.71M
P/E Ratio:
-1.1198
EPS:
-7.26
Net Cash Flow:
$-514.43M
1W Performance:
+11.77%
1M Performance:
-20.41%
6M Performance:
-45.88%
1Y Performance:
+50.84%
1-Day Range:
Value
$7.955
$8.18
1-Week Range:
Value
$6.81
$8.18
52-Week Range:
Value
$3.5324
$23.86

Novavax Inc Stock (NVAX) Company Profile

Name
Name
Novavax Inc
Name
Phone
240-268-2000
Name
Address
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Name
Employee
1,992
Name
Twitter
@novavax
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
NVAX's Discussions on Twitter

Compare NVAX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
NVAX 8.13 1.28B 793.74M -398.71M -514.43M -7.26
VRTX 448.10 115.74B 10.63B -479.80M -1.35B 13.33
REGN 742.93 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.76 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 250.01 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.66 24.49B 3.30B -501.07M 1.03B 11.54

Novavax Inc Stock (NVAX) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-09-23 Upgrade B. Riley Securities Neutral → Buy
Apr-20-23 Downgrade TD Cowen Outperform → Market Perform
Mar-01-23 Downgrade B. Riley Securities Buy → Neutral
Jan-09-23 Reiterated B. Riley Securities Buy
Dec-30-22 Reiterated H.C. Wainwright Buy
Dec-02-22 Initiated Jefferies Hold
Sep-22-22 Downgrade JP Morgan Neutral → Underweight
May-20-22 Initiated BofA Securities Underperform
Feb-23-22 Reiterated B. Riley Securities Buy
Feb-22-22 Resumed Jefferies Buy
Jan-21-22 Initiated Cowen Outperform
May-12-21 Downgrade JP Morgan Overweight → Neutral
Dec-14-20 Initiated Jefferies Buy
Aug-06-20 Reiterated H.C. Wainwright Buy
Aug-05-20 Upgrade JP Morgan Neutral → Overweight
Aug-05-20 Downgrade Ladenburg Thalmann Neutral → Sell
Jul-16-20 Reiterated H.C. Wainwright Buy
Jul-08-20 Downgrade Ladenburg Thalmann Buy → Neutral
Jun-29-20 Reiterated B. Riley FBR Buy
Jun-29-20 Reiterated H.C. Wainwright Buy
Jun-05-20 Upgrade JP Morgan Underweight → Neutral
May-28-20 Reiterated B. Riley FBR Buy
May-12-20 Reiterated H.C. Wainwright Buy
Apr-30-20 Reiterated H.C. Wainwright Buy
Nov-27-19 Resumed B. Riley FBR Buy
Aug-14-19 Reiterated H.C. Wainwright Buy
Feb-28-19 Downgrade Piper Jaffray Overweight → Underweight
Dec-18-18 Initiated Ladenburg Thalmann Buy
Dec-11-18 Initiated Oppenheimer Outperform
Nov-26-18 Upgrade Piper Jaffray Neutral → Overweight
Sep-21-18 Upgrade JP Morgan Underweight → Overweight
Mar-29-18 Upgrade Seaport Global Securities Neutral → Buy
View All

Novavax Inc Stock (NVAX) Latest News

pulisher
Nov 20, 2024

Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

Menopause Treatment Market Opportunities, Challenges, - openPR

Nov 20, 2024
pulisher
Nov 20, 2024

What is B. Riley's Estimate for Novavax FY2024 Earnings? - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Novavax to Present at Jefferies London Conference - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Preventive Vaccines Market May Set New Growth Story | Takeda - openPR

Nov 20, 2024
pulisher
Nov 18, 2024

Health Care Flat After Last Week's SelloffHealth Care Roundup - Marketscreener.com

Nov 18, 2024
pulisher
Nov 18, 2024

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance

Nov 18, 2024
pulisher
Nov 18, 2024

How To Trade (NVAX) - Stock Traders Daily

Nov 18, 2024
pulisher
Nov 18, 2024

FY2024 Earnings Forecast for Novavax Issued By HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Big Pharma Stocks Drop After RFK Jr. Announced as Health Secretary - Newsweek

Nov 15, 2024
pulisher
Nov 15, 2024

Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? - Yahoo! Voices

Nov 15, 2024
pulisher
Nov 15, 2024

UK regulator approves adapted Novavax jab - The Pharma Letter

Nov 15, 2024
pulisher
Nov 15, 2024

Health stocks slide as Trump picks vaccine skeptic Kennedy - Los Angeles Times

Nov 15, 2024
pulisher
Nov 15, 2024

Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department - New York Post

Nov 15, 2024
pulisher
Nov 15, 2024

Shot Down: Vaccine stocks tumble with RFK Jr. as Health SecretaryFinbold - Finbold - Finance in Bold

Nov 15, 2024
pulisher
Nov 15, 2024

Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma - The New York Times

Nov 15, 2024
pulisher
Nov 15, 2024

Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company

Nov 15, 2024
pulisher
Nov 15, 2024

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Malaysian Reserve

Nov 15, 2024
pulisher
Nov 15, 2024

Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill - Benzinga

Nov 15, 2024
pulisher
Nov 15, 2024

Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide. - Barron's

Nov 15, 2024
pulisher
Nov 15, 2024

Vaccine Maker Stocks Fall After Trump Taps RFK Jr. to Head HHS - MSN

Nov 15, 2024
pulisher
Nov 14, 2024

Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary - CNN

Nov 14, 2024
pulisher
Nov 14, 2024

Moderna, Novavax Shares Slip After Trump Names RFK Jr. Health Chief Nominee - Wall Street Pit

Nov 14, 2024
pulisher
Nov 14, 2024

Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

Big Pharma stocks tumble as Trump nominates RFK Jr. to lead HHS - The National Desk

Nov 14, 2024
pulisher
Nov 14, 2024

Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower - Benzinga

Nov 14, 2024
pulisher
Nov 14, 2024

Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Novavax to Participate in Jefferies London Healthcare Conference - StreetInsider.com

Nov 14, 2024
pulisher
Nov 14, 2024

Novavax Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Nov 13, 2024
pulisher
Nov 13, 2024

Novavax (NVAX) Stock Experiences Significant Drop Amid Industry Volatility - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Protein-based Vaccine Sales Strategy Advances - Precision Vaccinations

Nov 13, 2024
pulisher
Nov 13, 2024

Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Stock Market Increases While Tesla And Novavax Take A Hit - Finimize

Nov 13, 2024
pulisher
Nov 13, 2024

Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway (NASDAQ:NVAX) - Seeking Alpha

Nov 13, 2024
pulisher
Nov 13, 2024

Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic P - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Novavax Advances Vaccine Strategy Amid Financial Shifts - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Earnings call: Novavax outlines strategic growth and partnership with Sanofi - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Nov 12, 2024
pulisher
Nov 12, 2024

Novavax (NVAX) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Novavax Becomes Oversold (NVAX) - Nasdaq

Nov 12, 2024

Novavax Inc Stock (NVAX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Novavax Inc Stock (NVAX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Trizzino John
EVP, CCO and CBO
Aug 19 '24
Option Exercise
0.00
655
0
28,627
Kelly James Patrick
EVP, CFO and Treasurer
Aug 16 '24
Option Exercise
12.96
2,367
30,676
15,652
YOUNG JAMES F
Director
Jun 21 '24
Sale
14.09
7,500
105,675
61,760
YOUNG JAMES F
Director
Jun 18 '24
Sale
13.72
7,500
102,881
69,260
Dubovsky Filip
President, R&D
Jun 17 '24
Option Exercise
6.18
13,904
85,911
80,517
Dubovsky Filip
President, R&D
Jun 17 '24
Sale
14.47
13,904
201,164
66,613
MCGLYNN MARGARET G
Director
Jun 12 '24
Option Exercise
0.00
6,670
0
10,470
Alton Gregg H
Director
Jun 12 '24
Option Exercise
0.00
6,670
0
10,470
DOUGLAS RICHARD
Director
Jun 12 '24
Option Exercise
0.00
6,670
0
43,920
King Rachel K.
Director
Jun 12 '24
Option Exercise
0.00
6,670
0
18,920
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):